Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ngmL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans

BJU International

Volumn 106, Issue 8, 2010, Pages 1157-1160

  Caire, Arthur A ^a   Sun, Leon ^a   Polascik, Thomas J ^a   Albala, David M ^a   Moul, Judd W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

body mass index; obesity; prostate cancer; PSA recurrence; race; radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD LEVEL; BODY MASS; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE; SURGICAL APPROACH; SURGICAL TECHNIQUE; UNIVARIATE ANALYSIS;

AFRICAN AMERICANS; AGED; BODY MASS INDEX; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 77957581088     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09340.x     Document Type: Article

References (20)

1. Fegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005 293 : 1861 7
2. Jemal A, Siegel R, Ward E et al. Cancer statistics. CA Cancer J Clin 2008 58 : 71 96
3. Motamedinia P, Korets R, Spencer BA, Benson MC, McKiernan JM. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy. Urology 2008 72 : 1106 10
4. Freedland SJ, Aronson WJ, Kane CJ et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004 22 : 446 53
5. Powell IJ. Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 2007 177 : 444 9
6. Gonzalez JR, Consedine NS, McKiernan JM, Spencer BA. Barriers to the initiation and maintenance of prostate specific antigen screening in Black American and Afro-Caribbean men. J Urol 2008 180 : 2403 8
7. Tewari AK, Gold HT, Demers RY et al. Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology 2009 73 : 624 30
8. Spangler E, Zeigler-Johnson CM, Coomes M, Malkowicz SB, Wein A, Rebbeck TR. Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men. J Urol 2007 178 : 1939 45
9. Crawford ED. Epidemiology of prostate cancer. Urology 2003 62 : 3 12
10. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999 281 : 1591 7
11. Schroeck FR, Sun L, Freedland SJ, Jayachandran J, Robertson CN, Moul JW. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis 2008 11 : 371 6
12. Yanke BV, Carver BS, Bianco FJ Jr. et al. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. BJU Int 2006 98 : 783 7
13. Amling CL, Riffenburgh RH, Sun L et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004 22 : 439 45
14. Miller DC, Litwin MS, Bergman J et al. Prostate cancer severity among low income, uninsured men. J Urol 2009 181 : 579 84
15. Talcott JA, Spain P, Clark JA et al. Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer 2007 109 : 1599 606
16. Banez LL, Hamilton RJ, Partin AW et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007 298 : 2275 80
17. Hsing AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007 86 : s843 7
18. King CR, Spiotto MT, Kapp DS. Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy. Int J Radiat Oncol Biol Phys 2009 73 : 1017 22
19. Dahle SE, Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Hsing AW. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002 168 : 599 604
20. Hammarsten J, Hogstedt B. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 2005 41 : 2887 95